Insider
Date
Role
Action
Shares
Price
Amount
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,907
$251.24
$730.35K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,877
$250.49
$720.65K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
3,004
$249.40
$749.21K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,358
$248.38
$585.69K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
1,151
$246.98
$284.28K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
5,990
$246.26
$1.48M
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
3,818
$245.45
$937.14K
Gary M Pfeiffer
26 Oct 2026
Director
Sold on a plan
1,203
$243.00
$292.33K
J. E. Davis
1 Sep 2026
CEO and President
Sold on a plan
10,000
$242.72
$2.43M
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
430
$244.51
$105.14K
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
6,237
$243.63
$1.52M
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
16,010
$242.88
$3.89M
Mark E Delaney
28 Jul 2026
SVP & Chief Commercial Officer
Sold on a plan
1,600
$235.18
$376.29K
Karthik Kuppusamy
4 Jun 2026
SVP, Clinical Solutions
Sold after exercise
8,147
$200.00
$1.63M
J. E. Davis
1 Jun 2026
CEO and President
Sold on a plan
10,000
$194.14
$1.94M
Patrick Plewman
5 Mar 2026
SVP for Diagnostic Services
Sold on a plan
2,855
$206.21
$588.73K
Michael E Prevoznik
5 Mar 2026
SVP & General Counsel
Sold on a plan
3,878
$206.21
$799.68K
Catherine T. Doherty
5 Mar 2026
EVP, Regional Businesses
Sold on a plan
5,558
$206.21
$1.15M
Karthik Kuppusamy
4 Mar 2026
SVP, Clinical Solutions
Sell
2,628
$204.86
$538.37K
Patrick Plewman
3 Mar 2026
SVP for Diagnostic Services
Sold on a plan
410
$207.73
$85.17K
Michael E Prevoznik
3 Mar 2026
SVP & General Counsel
Sold on a plan
526
$207.73
$109.27K
Catherine T. Doherty
3 Mar 2026
EVP, Regional Businesses
Sold on a plan
632
$207.73
$131.29K
J. E. Davis
2 Mar 2026
CEO and President
Sold on a plan
10,000
$212.52
$2.13M
Catherine T. Doherty
19 Feb 2026
EVP, Regional Businesses
Sold on a plan
1,433
$204.83
$293.52K
Michael E Prevoznik
19 Feb 2026
SVP & General Counsel
Sold on a plan
1,111
$204.83
$227.57K
Patrick Plewman
19 Feb 2026
SVP for Diagnostic Services
Sold on a plan
958
$204.83
$196.23K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
351
$209.10
$73.39K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
1,619
$208.21
$337.09K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
3,500
$207.08
$724.79K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
10,122
$206.37
$2.09M
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
10,573
$205.21
$2.17M
Patrick Plewman
10 Feb 2026
SVP for Diagnostic Services
Sold after exercise
5,662
$204.00
$1.16M
Vicky B Gregg
25 Nov 2025
Director
Sell
1,250
$191.76
$239.70K
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
4,747
$192.97
$916.04K
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
41,004
$192.27
$7.88M
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
9,342
$191.59
$1.79M
Mark E Delaney
18 Nov 2025
SVP & Chief Commercial Officer
Sold after exercise
7,946
$187.35
$1.49M
Gary M Pfeiffer
22 Oct 2025
Director
Sell
1,482
$182.40
$270.32K
Michael E Prevoznik
26 Sep 2025
SVP & General Counsel
Sold after exercise
144
$188.66
$27.17K
Michael E Prevoznik
26 Sep 2025
SVP & General Counsel
Sold after exercise
83
$187.22
$15.54K
Michael E Prevoznik
24 Sep 2025
SVP & General Counsel
Sold after exercise
175
$187.02
$32.73K
Michael E Prevoznik
23 Sep 2025
SVP & General Counsel
Sold after exercise
28,288
$187.12
$5.29M
Patrick Plewman
21 Aug 2025
SVP for Diagnostic Services
Sold on a plan
1,975
$185.00
$365.38K
Patrick Plewman
19 Aug 2025
SVP for Diagnostic Services
Sold after exercise
4,532
$183.00
$829.36K
Patrick Plewman
15 Aug 2025
SVP for Diagnostic Services
Sold on a plan
1,975
$180.00
$355.50K
Patrick Plewman
6 Aug 2025
SVP for Diagnostic Services
Sold after exercise
1,975
$175.00
$345.63K
Patrick Plewman
6 Aug 2025
SVP for Diagnostic Services
Sold after exercise
3,560
$175.00
$623.00K
Karthik Kuppusamy
31 Jul 2025
SVP, Clinical Solutions
Sold on a plan
2,210
$170.00
$375.70K
Karthik Kuppusamy
30 Jul 2025
SVP, Clinical Solutions
Sold after exercise
5,224
$167.40
$874.50K
Karthik Kuppusamy
30 Jul 2025
SVP, Clinical Solutions
Sold after exercise
3,045
$167.40
$509.73K
Mark E Delaney
13 May 2025
SVP & Chief Commercial Officer
Sold on a plan
874
$175.31
$153.22K
Mark E Delaney
12 May 2025
SVP & Chief Commercial Officer
Sold on a plan
874
$175.72
$153.58K
Karthik Kuppusamy
2 Apr 2025
SVP, Clinical Solutions
Sold on a plan
2,555
$170.00
$434.35K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
453
$169.63
$76.84K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
902
$168.79
$152.25K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
1,493
$167.88
$250.64K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
267
$169.60
$45.28K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
584
$168.70
$98.52K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
750
$167.86
$125.90K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
2,493
$169.57
$422.74K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
5,900
$168.66
$995.12K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
6,950
$167.86
$1.17M
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
2,764
$169.56
$468.66K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
4,905
$168.72
$827.56K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
7,249
$167.86
$1.22M
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
704
$169.63
$119.42K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
1,411
$168.76
$238.11K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
2,366
$168.03
$397.55K
Michael E Prevoznik
17 Mar 2025
SVP & General Counsel
Sold on a plan
4,643
$170.00
$789.31K
Catherine T. Doherty
5 Mar 2025
EVP, Regional Businesses
Sold on a plan
5,370
$174.13
$935.08K
Michael E Prevoznik
4 Mar 2025
SVP & General Counsel
Sold on a plan
592
$175.79
$104.07K
Catherine T. Doherty
4 Mar 2025
EVP, Regional Businesses
Sold on a plan
716
$175.79
$125.87K
Catherine T. Doherty
27 Feb 2025
EVP, Regional Businesses
Sold on a plan
824
$172.61
$142.23K
Michael E Prevoznik
27 Feb 2025
SVP & General Counsel
Sold on a plan
528
$172.61
$91.14K
Catherine T. Doherty
20 Feb 2025
EVP, Regional Businesses
Sold on a plan
899
$170.99
$153.72K
Michael E Prevoznik
20 Feb 2025
SVP & General Counsel
Sold on a plan
604
$170.99
$103.28K
Catherine T. Doherty
19 Feb 2025
EVP, Regional Businesses
Sold on a plan
535
$169.71
$90.79K
Patrick Plewman
19 Feb 2025
SVP for Diagnostic Services
Sell
320
$169.71
$54.31K
Mark E Delaney
5 Feb 2025
SVP & Chief Commercial Officer
Sell
403
$164.30
$66.21K
Vicky B Gregg
5 Feb 2025
Director
Sell
1,250
$164.57
$205.71K
Michael E Prevoznik
29 Nov 2024
SVP & General Counsel
Sold after exercise
32,137
$163.15
$5.24M
Michael E Prevoznik
29 Nov 2024
SVP & General Counsel
Sold after exercise
3,009
$162.26
$488.24K
Catherine T. Doherty
27 Nov 2024
EVP, Regional Businesses
Sold after exercise
28,300
$163.13
$4.62M
Catherine T. Doherty
27 Nov 2024
EVP, Regional Businesses
Sold after exercise
4,803
$162.14
$778.78K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
5,189
$154.74
$802.96K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,331
$154.03
$359.05K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,600
$152.71
$397.05K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
4,135
$154.74
$639.83K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,400
$153.98
$369.56K
Michael J Deppe
6 Nov 2024
SVP, Corp. Controller & CAO
Sold after exercise
2,100
$152.70
$320.68K
Karthik Kuppusamy
28 Oct 2024
SVP, Clinical Solutions
Sell
1,775
$156.92
$278.53K
Michael E Prevoznik
29 Aug 2024
SVP & General Counsel
Sold after exercise
32,551
$154.97
$5.04M
Karthik Kuppusamy
28 Aug 2024
SVP, Clinical Solutions
Sell
1,990
$153.26
$304.99K
Mark E Delaney
24 Jul 2024
SVP & Chief Commercial Officer
Sell
420
$143.08
$60.09K
Karthik Kuppusamy
29 Apr 2024
SVP, Clinical Solutions
Sold on a plan
1,760
$140.00
$246.40K
Michael E Prevoznik
29 Feb 2024
SVP & General Counsel
Sold on a plan
5,611
$125.88
$706.31K
Catherine T. Doherty
29 Feb 2024
EVP, Regional Businesses
Sold on a plan
1,187
$125.88
$149.42K
Catherine T. Doherty
28 Feb 2024
EVP, Regional Businesses
Sold on a plan
5,557
$126.57
$703.35K
Vicky B Gregg
23 Feb 2024
Director
Sell
2,500
$126.64
$316.60K
Catherine T. Doherty
22 Feb 2024
EVP, Regional Businesses
Sold on a plan
821
$126.14
$103.56K
Michael E Prevoznik
22 Feb 2024
SVP & General Counsel
Sold on a plan
661
$126.14
$83.38K
Catherine T. Doherty
7 Mar 2023
SVP, Regional Businesses
Sell
5,307
$140.55
$745.90K
Michael E Prevoznik
7 Mar 2023
SVP & General Counsel
Sell
4,754
$140.55
$668.17K
Catherine T. Doherty
3 Mar 2023
SVP, Regional Businesses
Sell
717
$140.63
$100.83K
Michael E Prevoznik
2 Mar 2023
SVP & General Counsel
Sell
593
$138.54
$82.15K
Catherine T. Doherty
24 Feb 2023
SVP, Regional Businesses
Sell
1,690
$141.42
$239.00K
Michael E Prevoznik
24 Feb 2023
SVP & General Counsel
Sell
1,415
$141.42
$200.11K
Timothy M Ring
1 Dec 2022
Director
Sold after exercise
2,025
$152.50
$308.81K
Catherine T. Doherty
28 Nov 2022
SVP, Regional Businesses
Sold after exercise
23,407
$149.37
$3.50M
Catherine T. Doherty
28 Nov 2022
SVP, Regional Businesses
Sold after exercise
17,358
$148.92
$2.58M
Timothy M Ring
1 Nov 2022
Director
Sold after exercise
2,000
$144.06
$288.12K
Michael J Deppe
26 Oct 2022
VP, Corp. Controller & CAO
Sold after exercise
15,497
$145.00
$2.25M
Timothy M Ring
3 Oct 2022
Director
Sold after exercise
2,000
$123.39
$246.78K
Timothy M Ring
1 Sep 2022
Director
Sold after exercise
2,000
$125.02
$250.04K
Timothy M Ring
1 Aug 2022
Director
Sold after exercise
2,000
$136.04
$272.08K
Timothy M Ring
1 Jul 2022
Director
Sold after exercise
2,000
$133.47
$266.94K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
900
$142.13
$127.92K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
4,131
$141.35
$583.91K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
9,823
$140.58
$1.38M
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
651
$142.15
$92.54K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
2,565
$141.36
$362.59K
Stephen H Rusckowski
25 May 2022
Chairman, CEO and President
Sold after exercise
6,821
$140.60
$959.05K
Stephen H Rusckowski
24 May 2022
Chairman, CEO and President
Sold after exercise
156,282
$140.12
$21.90M
Stephen H Rusckowski
24 May 2022
Chairman, CEO and President
Sold after exercise
126,126
$140.12
$17.67M
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
300
$142.24
$42.67K
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
1,000
$141.51
$141.51K
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
41,268
$140.12
$5.78M
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
200
$142.26
$28.45K
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
800
$141.54
$113.23K
Stephen H Rusckowski
23 May 2022
Chairman, CEO and President
Sold after exercise
33,898
$140.12
$4.75M
Michael E Prevoznik
17 May 2022
SVP & General Counsel
Sold after exercise
50,604
$139.97
$7.08M
Catherine T. Doherty
8 Mar 2022
SVP, Group Exec. Clin. Fran.
Sell
7,032
$135.21
$950.80K
Michael E Prevoznik
8 Mar 2022
SVP & General Counsel
Sell
6,228
$135.21
$842.09K
Michael E Prevoznik
28 Feb 2022
SVP & General Counsel
Sell
661
$130.00
$85.93K
Michael E Prevoznik
24 Feb 2022
SVP & General Counsel
Sell
1,669
$126.26
$210.73K
Catherine T. Doherty
24 Feb 2022
SVP, Group Exec. Clin. Fran.
Sell
2,750
$126.26
$347.22K
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
14,575
$157.53
$2.30M
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
15,908
$156.86
$2.50M
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,532
$155.77
$550.19K
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,250
$154.79
$503.07K
Catherine T. Doherty
29 Nov 2021
SVP, Group Exec. Clin. Fran.
Sold after exercise
300
$153.38
$46.01K
Stephen H Rusckowski
29 Jul 2021
Chairman, CEO and President
Sold after exercise
4,193
$141.22
$592.12K
Stephen H Rusckowski
29 Jul 2021
Chairman, CEO and President
Sold after exercise
5,300
$140.59
$745.13K
Stephen H Rusckowski
28 Jul 2021
Chairman, CEO and President
Sold after exercise
139,751
$140.14
$19.58M
Gail R Wilensky
27 Jul 2021
Director
Sold after exercise
6,111
$139.27
$851.07K
Gail R Wilensky
27 Jul 2021
Director
Sold after exercise
6,111
$139.32
$851.40K
Stephen H Rusckowski
27 Jul 2021
Chairman, CEO and President
Sold after exercise
32,788
$140.01
$4.59M
Stephen H Rusckowski
26 Jul 2021
Chairman, CEO and President
Sold after exercise
5,813
$140.03
$813.99K
Catherine T. Doherty
7 May 2021
SVP, Group Exec. Clin. Fran.
Sell
8,536
$139.96
$1.19M
Michael E Prevoznik
5 May 2021
SVP & General Counsel
Sold after exercise
44,939
$137.00
$6.16M
Michael E Prevoznik
10 Mar 2021
SVP & General Counsel
Sell
5,574
$120.47
$671.50K
Michael E Prevoznik
25 Feb 2021
SVP & General Counsel
Sell
801
$115.49
$92.51K
Michael E Prevoznik
24 Feb 2021
SVP & General Counsel
Sell
750
$116.95
$87.71K
Michael E Prevoznik
24 Feb 2021
SVP & General Counsel
Sell
438
$116.95
$51.22K
Mark Guinan
24 Dec 2020
Executive Vice President & CFO
Sold after exercise
22,563
$121.18
$2.73M
Mark Guinan
24 Dec 2020
Executive Vice President & CFO
Sold after exercise
59,193
$120.06
$7.11M
Gail R Wilensky
24 Nov 2020
Director
Sold after exercise
6,111
$126.02
$770.12K
Daniel Stanzione
23 Nov 2020
Director
Sell
2,300
$127.45
$293.14K
Daniel Stanzione
23 Nov 2020
Director
Sell
3,302
$126.46
$417.58K
Daniel Stanzione
23 Nov 2020
Director
Sell
5,621
$125.73
$706.74K
Michael J Deppe
21 Oct 2020
VP, Corp. Controller & CAO
Sold after exercise
4,750
$125.00
$593.75K
Michael J Deppe
21 Oct 2020
VP, Corp. Controller & CAO
Sold after exercise
5,700
$125.00
$712.50K
Stephen H Rusckowski
16 Oct 2020
Chairman, CEO and President
Sold after exercise
291,997
$120.00
$35.04M
Michael E Prevoznik
14 Oct 2020
SVP & General Counsel
Sold after exercise
35,591
$119.00
$4.24M
Catherine T. Doherty
2 Sep 2020
SVP, Group Exec. Clin. Fran.
Sold after exercise
3,776
$111.13
$419.62K
Catherine T. Doherty
2 Sep 2020
SVP, Group Exec. Clin. Fran.
Sold after exercise
54,616
$110.57
$6.04M
Timothy M Ring
8 Jun 2020
Director
Sold after exercise
11,730
$116.60
$1.37M
Mark Guinan
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
8,524
$118.60
$1.01M
Mark Guinan
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
18,246
$117.65
$2.15M
Mark Guinan
8 Jun 2020
Executive Vice President & CFO
Sold after exercise
45,826
$116.81
$5.35M
Manner Carrie Eglinton
27 Apr 2020
SVP, Advanced Diagnostics
Sell
2,500
$110.00
$275.00K
Manner Carrie Eglinton
27 Apr 2020
SVP, Advanced Diagnostics
Sell
2,500
$112.03
$280.08K
Stephen H Rusckowski
27 Apr 2020
Chairman, CEO and President
Sold after exercise
11,717
$112.01
$1.31M
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
500
$90.15
$45.07K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
421
$88.53
$37.27K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
1,307
$87.81
$114.77K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
1,085
$86.65
$94.02K
J. E. Davis
16 Mar 2020
EVP, General Diagnostics
Sell
200
$85.59
$17.12K
Catherine T. Doherty
11 Mar 2020
SVP, Group Exec. Clin. Fran.
Sell
2,501
$104.25
$260.73K
Michael E Prevoznik
11 Mar 2020
SVP & General Counsel
Sell
2,175
$104.25
$226.74K
Stephen H Rusckowski
10 Mar 2020
Chairman, CEO and President
Sold after exercise
100
$112.19
$11.22K
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
2,000
$116.27
$232.54K
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
3,937
$115.45
$454.53K
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
16,426
$114.24
$1.88M
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
36,790
$113.65
$4.18M
Stephen H Rusckowski
6 Mar 2020
Chairman, CEO and President
Sold after exercise
171,025
$112.21
$19.19M
J. E. Davis
27 Feb 2020
EVP, General Diagnostics
Sell
1,100
$109.02
$119.92K
Catherine T. Doherty
27 Feb 2020
SVP, Group Exec. Clin. Fran.
Sell
789
$109.02
$86.02K
Michael E Prevoznik
27 Feb 2020
SVP & General Counsel
Sell
690
$109.02
$75.22K
J. E. Davis
26 Feb 2020
EVP, General Diagnostics
Sell
510
$111.09
$56.66K
Catherine T. Doherty
26 Feb 2020
SVP, Group Exec. Clin. Fran.
Sell
368
$111.09
$40.88K
Michael E Prevoznik
26 Feb 2020
SVP & General Counsel
Sell
321
$111.09
$35.66K
Catherine T. Doherty
25 Feb 2020
SVP, Group Exec. Clin. Fran.
Sell
405
$112.73
$45.66K
J. E. Davis
25 Feb 2020
EVP, General Diagnostics
Sell
598
$112.73
$67.41K
J. E. Davis
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
8,853
$106.51
$942.94K
J. E. Davis
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
69,003
$105.45
$7.28M
J. E. Davis
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
7,423
$106.51
$790.65K
J. E. Davis
2 Jan 2020
EVP, General Diagnostics
Sold after exercise
58,258
$105.46
$6.14M
Michael E Prevoznik
27 Nov 2019
SVP & General Counsel
Sold after exercise
500
$107.83
$53.92K
Michael E Prevoznik
27 Nov 2019
SVP & General Counsel
Sold after exercise
32,193
$107.53
$3.46M
Michael E Prevoznik
27 Nov 2019
SVP & General Counsel
Sold after exercise
11,863
$107.15
$1.27M
Gail R Wilensky
26 Nov 2019
Director
Sold after exercise
8,000
$107.17
$857.35K
Michael J Deppe
17 Sep 2019
VP, Corp. Controller & CAO
Sold after exercise
5,000
$106.00
$530.00K
Mark Guinan
13 Jun 2019
Executive Vice President & CFO
Sold after exercise
73,005
$100.00
$7.30M
Stephen H Rusckowski
13 Jun 2019
Chairman, President and CEO
Sold after exercise
244,565
$100.00
$24.46M
J. E. Davis
24 Apr 2019
EVP, General Diagnostics
Sold after exercise
47,574
$95.00
$4.52M
J. E. Davis
8 Apr 2019
EVP, General Diagnostics
Sell
2,100
$90.70
$190.48K
J. E. Davis
8 Apr 2019
EVP, General Diagnostics
Sell
5,900
$90.15
$531.86K
Catherine T. Doherty
4 Apr 2019
SVP, Group Exec. Clin. Fran.
Sold after exercise
5,890
$90.59
$533.59K
Catherine T. Doherty
4 Apr 2019
SVP, Group Exec. Clin. Fran.
Sold after exercise
60,492
$90.59
$5.48M
Everett Cunningham
4 Mar 2019
SVP, Commercial
Sell
3,892
$86.81
$337.86K
Michael E Prevoznik
4 Mar 2019
SVP & General Counsel
Sell
3,373
$86.81
$292.81K
Everett Cunningham
27 Feb 2019
SVP, Commercial
Sell
1,144
$86.51
$98.97K
Michael E Prevoznik
27 Feb 2019
SVP & General Counsel
Sell
1,048
$86.51
$90.66K
Everett Cunningham
26 Feb 2019
SVP, Commercial
Sell
352
$87.06
$30.65K
Michael E Prevoznik
26 Feb 2019
SVP & General Counsel
Sell
364
$87.06
$31.69K
Everett Cunningham
25 Feb 2019
SVP, Commercial
Sell
326
$88.23
$28.76K
Michael E Prevoznik
25 Feb 2019
SVP & General Counsel
Sell
336
$88.23
$29.65K
Gail R Wilensky
22 Feb 2019
Director
Sold after exercise
8,000
$87.78
$702.22K
Everett Cunningham
10 Jul 2018
SVP, Commercial
Sold after exercise
40,328
$112.00
$4.52M
Michael E Prevoznik
10 Jul 2018
SVP & General Counsel
Sold after exercise
30,780
$113.07
$3.48M
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
781
$110.12
$86.01K
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
7,066
$109.63
$774.62K
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
5,583
$110.07
$614.50K
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
33,345
$109.60
$3.65M
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
1,496
$110.12
$164.74K
Everett Cunningham
2 Jul 2018
SVP, Commercial
Sold after exercise
19,798
$109.64
$2.17M
Jeffrey M Leiden
29 May 2018
Director
Sell
1,644
$105.61
$173.62K
Mark Guinan
25 May 2018
Executive Vice President & CFO
Sold after exercise
24,960
$106.14
$2.65M
Mark Guinan
25 May 2018
Executive Vice President & CFO
Sold after exercise
36,573
$105.42
$3.86M
Stephen H Rusckowski
25 May 2018
Chairman, President and CEO
Sold after exercise
168,490
$107.00
$18.03M
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
7,773
$104.77
$814.38K
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
2,800
$104.77
$293.36K
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
34,168
$104.09
$3.56M
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
1,300
$104.77
$136.20K
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
18,164
$104.09
$1.89M
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
1,427
$104.76
$149.49K
Jon R Cohen
8 Mar 2018
SVP & Group Exec. Diag. Sol.
Sold after exercise
18,037
$104.09
$1.88M
Catherine T. Doherty
5 Mar 2018
SVP, Group Exec. Clin. Fran.
Sell
5,556
$101.00
$561.16K
J. E. Davis
5 Mar 2018
EVP, General Diagnostics
Sell
5,122
$101.00
$517.32K
Michael E Prevoznik
5 Mar 2018
SVP & General Counsel
Sell
4,128
$101.00
$416.93K
J. E. Davis
28 Feb 2018
EVP, General Diagnostics
Sell
648
$104.99
$68.03K
Catherine T. Doherty
28 Feb 2018
SVP, Group Exec. Clin. Fran.
Sell
572
$104.99
$60.05K
Michael E Prevoznik
28 Feb 2018
SVP & General Counsel
Sell
496
$104.99
$52.08K
J. E. Davis
27 Feb 2018
EVP, General Diagnostics
Sell
1,150
$104.10
$119.72K
Catherine T. Doherty
27 Feb 2018
SVP, Group Exec. Clin. Fran.
Sell
1,248
$104.10
$129.92K
Michael E Prevoznik
27 Feb 2018
SVP & General Counsel
Sell
927
$104.10
$96.50K
J. E. Davis
26 Feb 2018
EVP, General Diagnostics
Sell
494
$102.74
$50.75K
Catherine T. Doherty
26 Feb 2018
SVP, Group Exec. Clin. Fran.
Sell
397
$102.74
$40.79K
Robert A Klug
26 Feb 2018
VP, Corporate Controller
Sell
1,157
$103.66
$119.93K
